NCT06285877

Brief Summary

Purpose: to observe the possible benefits produced by conventional therapy through virtual reality with the Nintendo Switch to try to improve motivation and increase the degree of care satisfaction. The aim is to improve postural control in both seated and standing positions and to maintain and improve cognitive capacity. Material and methods: one group (experimental group) will receive a total of 8 one-hour sessions or 16 half-hour sessions, depending on their individual needs, for 8 weeks using the Nintendo Switch. The other group (control group) will continue to receive their conventional scheduled therapy. Measures: Abilhand, MEC-Lobo, FIST, Fugl-Meyer, Berg Balance Scale and CSQ-8.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

February 1, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
28 days until next milestone

First Posted

Study publicly available on registry

February 29, 2024

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

February 29, 2024

Status Verified

February 1, 2024

Enrollment Period

Same day

First QC Date

January 30, 2024

Last Update Submit

February 28, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Abilhand

    It is an assessment test that measures the degree of difficulty perceived by the patient in performing the 23 activities of daily living.

    Pre-intervention and post-intervention (up to 1-2 weeks)

  • MEC-Lobo

    This is a scale that allows us to evaluate the cognitive status of patients. The lower the score, the greater the cognitive impairment.

    Pre-intervention and post-intervention (up to 1-2 weeks)

  • Function in Sitting Test (FIST)

    It is a scale that assesses the postural control deficits presented by the patient in sedentary position in the event of imbalance, reaching on the floor, etc.

    Pre-intervention and post-intervention (up to 1-2 weeks)

  • Fugl-Meyer

    This scale assesses the patient's motor function, sensory function, muscle balance, range of joint mobility and joint pain.

    Pre-intervention and post-intervention (up to 1-2 weeks)

  • Berg Balance Scale (BBS)

    The scale is used to measure balance mainly in standing position in patients with different types of pathologies.

    Pre-intervention and post-intervention (up to 1-2 weeks)

Secondary Outcomes (1)

  • Client Satisfaction Questionnaire (CSQ-8)

    Post-intervention (up to 1-2 weeks)

Study Arms (2)

Control Group

ACTIVE COMPARATOR

Control Group (CG) which received their usual sessions of conventional therapy.

Procedure: Conventional therapy sessions

Experimental Group

EXPERIMENTAL

Experimental Group (EG) which received therapy with Nintendo Switch plus their usual sessions of conventional therapy.

Procedure: Conventional therapy sessions plus Nintendo Switch

Interventions

Conventional sessions are neuropsychology, speech therapy, physiotherapy and occupational therapy treatments. They are based on cognitive stimulation, manipulative dexterity, therapeutic exercise.

Control Group

Conventional sessions are neuropsychology, speech therapy, physiotherapy and occupational therapy treatments. They are based on cognitive stimulation, manipulative dexterity, therapeutic exercise plus one hour a week of Nintendo Switch.

Experimental Group

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult men and women, over 30 years of age who have suffered an acquired brain injury.
  • Mild or moderate cognitive impairment as measured by the MEC-Lobo test (score greater than 23/35).
  • Regularly attend some conventional therapy (neuropsychology, physiotherapy or occupational therapy).
  • Agree to participate voluntarily by signing the informed consent form.

You may not qualify if:

  • Present severe cognitive impairment as measured by the MEC-Lobo test (less than 23/35).
  • Present aphasia of comprehension or expression.
  • Present associated neurodegenerative pathology.
  • Present any pathology underlying the acquired brain damage (diabetes, heart disease, COPD, etc.), heart disease, COPD, etc.).
  • Voluntarily refuse to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Rey Juan Carlos

Móstoles, Madrid, 28933, Spain

RECRUITING

MeSH Terms

Conditions

Brain Injuries

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Isabel Quirosa Galan, MsC

    Universidad Rey Juan Carlos

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Isabel Quirosa Galan, MsC

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Control Group (CG), which received their usual sessions of conventional therapy sessions, and an Experimental Group (EG), which received therapy with Nintendo Switch plus their conventional therapy sessions.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Occupational Therapist, MsC

Study Record Dates

First Submitted

January 30, 2024

First Posted

February 29, 2024

Study Start

February 1, 2024

Primary Completion

February 1, 2024

Study Completion

January 1, 2025

Last Updated

February 29, 2024

Record last verified: 2024-02

Locations